131 related articles for article (PubMed ID: 34028418)
41. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
[TBL] [Abstract][Full Text] [Related]
42. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
Rubello D; Mazzarotto R; Casara D
Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
[TBL] [Abstract][Full Text] [Related]
43. Incidental multifocal papillary microcarcinomas of the thyroid: is subtotal thyroidectomy combined with radioiodine ablation enough?
Dietlein M; Luyken WA; Schicha H; Larena-Avellaneda A
Nucl Med Commun; 2005 Jan; 26(1):3-8. PubMed ID: 15604941
[TBL] [Abstract][Full Text] [Related]
44. An unusual case of papillary carcinoma of the thyroid with cutaneous and breast metastases only.
Loureiro MM; Leite VH; Boavida JM; Raposo JF; Henriques MM; Limbert ES; Sobrinho LG
Eur J Endocrinol; 1997 Sep; 137(3):267-9. PubMed ID: 9330591
[TBL] [Abstract][Full Text] [Related]
45. [Application of recombinant human TSH in the diagnostic protocol of differentiated thyroid carcinoma].
Jiménez-Hoyuela García JM; García Almeida JM; Delgado García A; Aguilar Fernández I; Martínez del Valle Torres MD; Ortega Lozano S; Rebollo Aguirre A; Mancha Doblas I; Pinzón Martín JL; Picón César MJ; Zamorano Vázquez D
Rev Esp Med Nucl; 2005; 24(3):152-60. PubMed ID: 15847782
[TBL] [Abstract][Full Text] [Related]
46. [Recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma].
Gómez Camarero P; Martínez Brocca MA; Rodríguez Rodríguez JR; Navarro González E; Tirado Hospital JL; González Duarte D; Vázquez Albertino R; Astorga Jimenez R
Rev Esp Med Nucl; 2003; 22(5):295-305. PubMed ID: 14534005
[TBL] [Abstract][Full Text] [Related]
47. False-Positive 131I Uptake in a Benign Bone Lesion on Post-therapy Scan.
Yazici B; Oral A; Eraslan C; Argin M; Ömür Ö
Clin Nucl Med; 2016 Jan; 41(1):e63-5. PubMed ID: 26252335
[TBL] [Abstract][Full Text] [Related]
48. Thyroglobulin and 131I uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy.
Moser E; Fritsch S; Braun S
Nucl Med Commun; 1988 Apr; 9(4):262-6. PubMed ID: 3399222
[TBL] [Abstract][Full Text] [Related]
49. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease.
Yunusa GH; Kotze T; Brink A
Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115
[TBL] [Abstract][Full Text] [Related]
50. Role of [
Xu Q; Liu R; Wang J; Huang Y; Li S; Zhang L; Wang F
Nucl Med Biol; 2020; 88-89():34-43. PubMed ID: 32688289
[TBL] [Abstract][Full Text] [Related]
51. Detection of distant metastasis at the time of ablation in children with differentiated thyroid cancer: the value of pre-ablation stimulated thyroglobulin.
Liu L; Huang F; Liu B; Huang R
J Pediatr Endocrinol Metab; 2018 Jul; 31(7):751-756. PubMed ID: 29953410
[TBL] [Abstract][Full Text] [Related]
52. Surveillance of patients to detect recurrent thyroid carcinoma.
Grigsby PW; Baglan K; Siegel BA
Cancer; 1999 Feb; 85(4):945-51. PubMed ID: 10091774
[TBL] [Abstract][Full Text] [Related]
53. Effect of postoperative 131I treatment on thyroglobulin measurements in the follow-up of patients with thyroid cancer.
Baskin HJ
Thyroid; 1994; 4(3):239-42. PubMed ID: 7833657
[TBL] [Abstract][Full Text] [Related]
54. 131I Whole-Body Scan Incidental Uptake Due to Spermatocele.
Albano D; Motta F; Baronchelli C; Lucchini S; Bertagna F
Clin Nucl Med; 2017 Nov; 42(11):901-904. PubMed ID: 28902733
[TBL] [Abstract][Full Text] [Related]
55. Positron emission tomography for the detection of metastases of differentiated thyroid carcinoma.
Lips P; Comans EF; Hoekstra OS; van der Poest Clement E; van Mourik JC; Teule GJ
Neth J Med; 2000 Oct; 57(4):150-6. PubMed ID: 11006491
[TBL] [Abstract][Full Text] [Related]
56. Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation.
Lin JD; Chao TC; Huang MJ; Weng HF; Tzen KY
Am J Clin Oncol; 1998 Feb; 21(1):77-81. PubMed ID: 9499265
[TBL] [Abstract][Full Text] [Related]
57. Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy.
de Klerk JM; de Keizer B; Zelissen PM; Lips CM; Koppeschaar HP
Nucl Med Commun; 2000 Jun; 21(6):529-32. PubMed ID: 10894561
[TBL] [Abstract][Full Text] [Related]
58. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma.
Harder W; Lind P; Molnar M; Mikosch P; Gomez I; Gallowitsch HJ; Kresnik E; Unterweger O; Dinges HP
J Nucl Med; 1998 Feb; 39(2):236-8. PubMed ID: 9476925
[TBL] [Abstract][Full Text] [Related]
59. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma.
Lindegaard MW; Paus E; Høie J; Kullman G; Stenwig AE
Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295
[TBL] [Abstract][Full Text] [Related]
60. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
Salvatori M; Perotti G; Rufini V; Maussier ML; Dottorini M
Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
